Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Fukushima, Satsuki ^a   Coppen, Steven R ^b   Lee, Joon ^a   Yamahara, Kenichi ^a   Felkin, Leanne E ^a   Terracciano, Cesare M N ^a   Barton, Paul J R ^a   Yacoub, Magdi H ^a   Suzuki, Ken ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GRAFT SURVIVAL; HEART FAILURE; HEART FUNCTION; HEART GRAFT; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; INJECTION SITE; INTRAMYOCARDIAL INJECTION; NONHUMAN; PHYSICAL ACTIVITY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MYOBLAST TRANSPLANTATION; SPRAGUE DAWLEY RAT; TELEMETRY; TREATMENT RESPONSE; WILD TYPE; Y CHROMOSOME; ANIMAL; CELL TRANSPLANTATION; DISEASE MODEL; GENETICS; HEART FUNCTION TEST; METHODOLOGY; MYOBLAST; REPORTER GENE; TRANSPLANTATION;

RATTUS;

GREEN FLUORESCENT PROTEIN;

ANIMALS; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEART FAILURE; HEART FUNCTION TESTS; MYOBLASTS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 52449086662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003071     Document Type: Article

References (33)

1. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, et al. (2005) Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112: 1748-1755.
2. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, et al. (2004) Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 148: 531-537.
3. Hagege AA, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, et al. (2006) Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114: 1108-1113.
4. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, et al. (2003) Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-2069.
5. Reinecke H, Poppa V, Murry CE (2002) Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34: 241-249.
6. Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, et al. (2007) Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115: 2254-2261.
7. Suzuki K, Brand NJ, Smolenski RT, Jayakumar J, Murtuza B, et al. (2000) Development of a novel method for cell transplantation through the coronary artery. Circulation 102: 359-364.
8. Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, et al. (2004) Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac Function. Circulation 110: II225-II230.
9. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, et al. (2006) Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113: 1287-1294.
10. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, et al. (2001) Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104: I207-I212.
11. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, et al. (1999) Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol 277: H1967-H1974.
12. Kovacs SJ, Rosado J, Manson McGuire AL, Hall AF (1997) Can trasmitral Doppler E-waves differentiate hypertensive hearts from normal? Hypertension 30: 788-795.
13. Fernandes S, Amirault JC, Lande G, Nguyen JM, Forest V, et al. (2006) Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res 69: 348-358.
14. Howarth FC, Jacobson M, Shafiullah M, Adeghate E (2006) Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat. Clin Exp Pharmacol Physiol 33: 327-331.
15. MacDonnell SM, Kubo H, Crabbe DL, Renna BF, Reger PO, et al. (2005) Improved myocardial beta-adrenergic responsiveness and signaling with exercise training in hypertension. Circulation 111: 3420-3428.
16. Coppen SR, Kodama I, Boyett MR, Dobrzynski H, Takagishi Y, et al. (1999) Connexin45, a major connexin of the rabbit sinoatrial node, is co-expressed with connexin43 in a restricted zone at the nodal-crista terminalis, border. J Histochem Cytochem 47: 907-918.
17. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, et al. (2WO) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62.
18. Zheng Z, Liu Z (2006) CD151 gene delivery activates PI3K/Akt pathway and promotes neovascularization after myocardial infarction in rats. Mol Med 12: 214-220.
19. Niagara MI, Haider HK, Jiang S, Ashraf M (2007) Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart. Circ Res 100: 545-555.
20. Felkin LE, Birks EJ, George R, Wong S, Khaghani A, et al. (2006) A Quantitative Gene Expression Profile of Matrix Metalloproteinases (MMPS) and Their Inhibitors (TIMPS) in the Myocardium of Patients With Deteriorating Heart Failure Requiring Left Ventricular Assist Device Support. The Journal of Heart and Lung Transplantation 25: 1413-1419.
21. Hering S, Bodewei R, Wollenberger A (1983) Sodium current in freshly isolated and in cultured single rat myocardial cells: frequency and voltage-dependent block by mexiletine. J Mol Cell Cardiol 15: 431-444.
22. Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, et al. (2003) Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Cell Cardiol 41: 1964-1971.
23. Bonaros N, Rauf R, Wolf D, Margreiter E, Tzankov A, et al. (2W6) Combined transplantation of skeletal myoblasts and angiopoiet0c progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. J Thorac Cardiovasc Surg 132: 1321-1328.
24. Bonaros N, Rauf R, Werner E, Schlechta B, Rohde E, et al. (2008) Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Interact Cardio Vasc Thorac Surg 7: 219-255.
25. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, et al. (2005) Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 97: 159-167.
26. Fouts K, Fernandes B, Mal N, Liu J, Laurita KR (2006) Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm 3: 452-461.
27. Ott HC, Kroess R, Bonaros N, Marksteiner R, Margreiter E, et al. (2005) Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation. Eur J Cardiothorac Surg 27: 1017-1021.
28. Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, et al. (2004) Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 95 Suppl 1: S29-S33.
29. Suzuki K, Sawa Y, Kaneda Y, Ichikawa H, Shirakura R, et al. (1997) In Vivo Gene Transfection with Heat Shock Protein 70 Enhances Myocardial Tolerance to Ischemia-Reperfusion Injury in Rat. J Clin Invest 99: 1645-1650.
30. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465.
31. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
32. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, et al. (2002) Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34: 107-116.
33. Orofino MG, Contu D, Argiolu F, Sanna MA, Gaziev J, et al. (2006) No influence of chromosome y haplogroup variation in acute graft-versus-host disease in sardinia. Transplantation 82: 1529-1532.